As of 4:00pm ET
| +0.01 / +0.41%|
The 2 analysts offering 12-month price forecasts for Windtree Therapeutics Inc have a median target of 21.50, with a high estimate of 35.00 and a low estimate of 8.00. The median estimate represents a +781.15% increase from the last price of 2.44.
The current consensus among 2 polled investment analysts is to Buy stock in Windtree Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.